Eisai
4523.T
#2011
Rank
NZ$13.78 B
Marketcap
$48.91
Share price
-0.53%
Change (1 day)
-37.76%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Market capitalization of Eisai (4523.T)

Market cap: NZ$13.78 Billion

As of December 2024 Eisai has a market cap of NZ$13.78 Billion. This makes Eisai the world's 2011th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Eisai from 2000 to 2024

End of year Market Cap

Year Marketcap Change
2024NZ$13.78 B-39.21%
2023NZ$22.67 B-22.86%
2022NZ$29.40 B23.42%
2021NZ$23.82 B-16.1%
2020NZ$28.39 B-11.42%
2019NZ$32.05 B-2.54%
2018NZ$32.88 B43.63%
2017NZ$22.89 B-3.86%
2016NZ$23.81 B-14.74%
2015NZ$27.93 B96.18%
2014NZ$14.23 B5.69%
2013NZ$13.47 B-7.14%
2012NZ$14.50 B-3.11%
2011NZ$14.97 B12.37%
2010NZ$13.32 B-7.71%
2009NZ$14.43 B-30.78%
2008NZ$20.85 B36.71%
2007NZ$15.25 B-31.59%
2006NZ$22.30 B27.15%
2005NZ$17.54 B32.31%
2004NZ$13.25 B8%
2003NZ$12.27 B-1.91%
2002NZ$12.51 B-29.2%
2001NZ$17.67 B-24.44%
2000NZ$23.39 B